Literature DB >> 8663278

Syk-dependent phosphorylation of Shc. A potential link between FcepsilonRI and the Ras/mitogen-activated protein kinase signaling pathway through SOS and Grb2.

B Jabril-Cuenod1, C Zhang, A M Scharenberg, R Paolini, R Numerof, M A Beaven, J P Kinet.   

Abstract

Antigen receptors on T- and B-cells activate Ras through a signaling pathway that results in the tyrosine phosphorylation of Shc and the formation of a complex of Shc with the Grb2 adaptor protein. The high affinity receptor for immunoglobulin E (FcepsilonRI) in cultured mast (RBL-2H3) cells has been reported to function differently. Here we show to the contrary that engagement of FcepsilonRI with antigen leads to increased tyrosine phosphorylation of Shc and the association of Shc with Grb2 and other proteins (p120 and p140). Like the FcepsilonRI-mediated activation of the mitogen-activated protein kinase cascade, these responses are dependent on the tyrosine kinase Syk; they are enhanced by overexpression of Syk and are blocked by expression of dominant-negative Syk. Sos is constitutively associated with Grb2 in these cells but dissociates from Shc on stimulation with antigen. These reactions are rapid, reversible, and associated with the activation of Ras. Therefore, the Syk-dependent tyrosine phosphorylation of Shc and its association with Grb2 may provide a pathway through Sos for activation of Ras by FcepsilonRI.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8663278     DOI: 10.1074/jbc.271.27.16268

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Independent and cooperative roles of adaptor molecules in proximal signaling during FcepsilonRI-mediated mast cell activation.

Authors:  Taku Kambayashi; Mariko Okumura; Rebecca G Baker; Chih-Jung Hsu; Tobias Baumgart; Weiguo Zhang; Gary A Koretzky
Journal:  Mol Cell Biol       Date:  2010-07-06       Impact factor: 4.272

Review 2.  Involvement of Fc receptors in disorders of the central nervous system.

Authors:  Eitan Okun; Mark P Mattson; Thiruma V Arumugam
Journal:  Neuromolecular Med       Date:  2009-10-21       Impact factor: 3.843

3.  The human high-affinity immunoglobulin G receptor activates SH2-containing inositol phosphatase (SHIP).

Authors:  A J Cameron; J M Allen
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

4.  Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha IIb beta 3.

Authors:  J Gao; K E Zoller; M H Ginsberg; J S Brugge; S J Shattil
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

5.  Shc contains two Grb2 binding sites needed for efficient formation of complexes with SOS in B lymphocytes.

Authors:  S L Harmer; A L DeFranco
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

6.  Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell Activation.

Authors:  Hiam Abdala-Valencia; Paul J Bryce; Robert P Schleimer; Joshua B Wechsler; Lucas F Loffredo; Joan M Cook-Mills; Chia-Lin Hsu; Sergejs Berdnikovs
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

Review 7.  Adapters in the organization of mast cell signaling.

Authors:  Damiana Alvarez-Errico; Eva Lessmann; Juan Rivera
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

8.  The tyrosine kinase Syk promotes phagocytosis of Francisella through the activation of Erk.

Authors:  Kishore V L Parsa; Jonathan P Butchar; Murugesan V S Rajaram; Thomas J Cremer; Susheela Tridandapani
Journal:  Mol Immunol       Date:  2008-03-04       Impact factor: 4.407

9.  Differential regulation of mast cell cytokines by both dexamethasone and the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580.

Authors:  R D Koranteng; E J Swindle; B J Davis; R J Dearman; I Kimber; B F Flanagan; J W Coleman
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

10.  Quantitative time-resolved phosphoproteomic analysis of mast cell signaling.

Authors:  Lulu Cao; Kebing Yu; Cindy Banh; Vinh Nguyen; Anna Ritz; Benjamin J Raphael; Yuko Kawakami; Toshiaki Kawakami; Arthur R Salomon
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.